Resources Investment Advisors, Llc. Genprex, Inc. Transaction History

Resources Investment Advisors, Llc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$1.82 - $3.5 $24,115 - $46,375	-13,250 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$1.21 - $2.7 $905 - $2,019	-748 Reduced 5.34%	13,250 $17,000
Q3 2021 Nov 05, 2021	BUY	$2.59 - $3.36 $518 - $672	200 Added 1.45%	13,998 $37,000
Q2 2021 Aug 09, 2021	BUY	$3.11 - $4.87 $1,244 - $1,948	400 Added 2.99%	13,798 $46,000
Q1 2021 May 10, 2021	BUY	$3.66 - $7.67 $2,196 - $4,602	600 Added 4.69%	13,398 $57,000
Q4 2020 Feb 08, 2021	BUY	$3.03 - $5.51 $7,726 - $14,050	2,550 Added 24.88%	12,798 $53,000
Q3 2020 Oct 09, 2020	BUY	$2.9 - $4.29 $29,719 - $43,963	10,248 New	10,248 $34,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $112M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.